Articles on this page are updated by ProfileData Research on an hourly basis. To see the summary of the SENS notice, please click on the headline. To read the original SENS message, please click on the link in the summary.



Date Headline/Title
08 December 2015Report on Annual General Meeting Proceedings
01 December 2015Voluntary announcement - Aspen acquires the rights to Hydroxyprogesterone Caproate Injection (HPC)
19 November 2015Dealing in Aspen securities by the Company Secretary of Aspen
10 November 2015Dealing in securities by directors and by directors of a major subsidiary
03 November 2015No change statement and AGM notice
22 October 2015Dealing in Aspen securities by a director of Aspen
13 October 2015Dealing in Aspen securities by the Aspen Share Incentive Trust
09 October 2015Dealing in securities by directors company secretary and directors of a major subsidiary
02 October 2015Dealing in Aspen securities by a director of Aspen
25 September 2015Dealing in Aspen securities by a director of Aspen
09 September 2015Aspen final results June 2015
07 September 2015Aspens results for the year ended 30 June 2015 and year-end results presentations
28 August 2015Trading statement
12 August 2015Resignation as Directors and Chairman / Appointment of Chairman
11 August 2015Divestment of portfolio
05 August 2015Renewal of Cautionary Announcement- Possible Infant Nutritionals Business Acquisition
30 June 2015Changes in Aspens Black Economic Empowerment Shareholding
25 June 2015Renewal of Cautionary Announcement- Possible Infant Nutritionals Business Acquisition
21 May 2015Divestment of Portfolio of Branded and Generic Products to Strides Entities
14 May 2015Cautionary Announcement
11 May 2015Divestment of South African Business Unit to Litha
20 March 2015Notification in terms of Section 122(3) of The Companies Act and Section 3.83(b) of the JSE Listings Requirements
20 March 2015Resignation of independent non-executive director Mogammed Rafique Bagus
17 March 2015Dealing in securities by directors
13 March 2015GSK announces completion of the sale of half its stake in Aspen
05 March 2015Aspen interim results Decemeber 2014
26 February 2015Trading Statement
23 February 2015Aspen interim results release & presentation
23 January 2015ACQUISITION OF RIGHTS TO AN ANTI-COAGULENT PRODUCT FROM NOVARTIS
Powered by ProfileData